Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Matthew Davids, MD, Dana-Farber Cancer Institute, Boston, MA, speaking at the 18th International Workshop on Chronic Lymphocytic (iwCLL) Biennial Meeting, held in Edinburgh, UK. Davids speaks on achieving measurable residual disease (MRD( negativity through novel combination therapies, touching on current treatment options for Richter’s syndrome.
We use cookies to provide the best experience on our website. We also use third party cookies to collect analytical data and better improve our marketing strategies. If you continue to use this site you are consenting to the use of these cookies. For more information view our Cookie Policy.